These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 4348133)

  • 1. A modified method for the isolation of melanosomes from B16 melanoma.
    Haberman HF; Menon IA
    J Invest Dermatol; 1973 Feb; 60(2):67-72. PubMed ID: 4348133
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas.
    Menon IA; Haberman HF
    Arch Biochem Biophys; 1970 Mar; 137(1):231-42. PubMed ID: 4985092
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid phosphatase activity in melanosomes of melanocytes.
    Kikuchi A
    Bull Tokyo Med Dent Univ; 1968 Dec; 15(4):279-94. PubMed ID: 5253262
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
    Hamada T; Mishima Y
    Br J Dermatol; 1972 Apr; 86(4):385-94. PubMed ID: 4623455
    [No Abstract]   [Full Text] [Related]  

  • 9. False dopa reaction in studies of mammalian tyrosinase: some characteristics and precautions.
    White R; Hu F; Roman NA
    Stain Technol; 1983 Jan; 58(1):13-9. PubMed ID: 6410541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolation and chemical composition of premelanosomes and melanosomes: human and mouse melanomas.
    Siakotos AN; Patel V; Cantaboni A
    Biochem Med; 1973 Feb; 7(1):14-24. PubMed ID: 4346133
    [No Abstract]   [Full Text] [Related]  

  • 11. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanosome and lysosome. I. Lysosomal activity in relation to growth of melanoma.
    Otaki N
    Bull Tokyo Med Dent Univ; 1970 Jun; 17(2):89-102. PubMed ID: 4989159
    [No Abstract]   [Full Text] [Related]  

  • 13. Tyrosinase in melanized melanosomes.
    Seiji M; Fukuzawa H
    Tohoku J Exp Med; 1972 Nov; 108(3):291-302. PubMed ID: 4197851
    [No Abstract]   [Full Text] [Related]  

  • 14. Electron microscopic and cytochemical observations of mast cells containing melanosomes in blue nevus.
    Sato S; Kukita A
    Acta Derm Venereol; 1974; 54(2):113-20. PubMed ID: 4133015
    [No Abstract]   [Full Text] [Related]  

  • 15. The subcellular distribution of lysosomal hydrolases in the Harding-Passey melanoma.
    Mufson RA
    J Cell Physiol; 1974 Feb; 83(1):75-83. PubMed ID: 4204977
    [No Abstract]   [Full Text] [Related]  

  • 16. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM
    Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T; Ono T; Arao T; Tomita Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y; Jimbow K
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.